Part 2: Management of Intraoperative and Perioperative Bleeding.
J Am Acad Dermatol
; 2024 May 13.
Article
em En
| MEDLINE
| ID: mdl-38750938
ABSTRACT
With an increase in number of patients on antithrombotic therapies, management of bleeding during dermatologic surgery is increasingly important. As described in Part 1, perioperative discontinuation of antithrombotic therapies may increase the risk of embolic events thus the risks and benefits must be weighed carefully when deciding whether to continue or suspend therapy. However, continuing oral anticoagulants may result in increased intraoperative and postoperative bleeding. Here we describe various methods to effectively achieve hemostasis which include 1) mechanical methods to compress the vasculature 2) pharmacologic agents that induce vasoconstriction 3) physiologic agents that augment clot formation and 4) physical agents that promote platelet aggregation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Am Acad Dermatol
/
J. Am. Acad. Dermatol
/
Journal of the American Academy of dermatology
Ano de publicação:
2024
Tipo de documento:
Article